Temazepam
Back to searchMolecule Structure
Scientific Name
Temazepam
Description of the Drug
Temazepam is a short-acting benzodiazepine commonly used to treat panic disorders, severe anxiety, and insomnia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00231
http://www.drugbank.ca/drugs/DB00231
Brand Name(s)
Kentepam, Normison, Restoril, Temaz, Temazepam
Company Owner(s)
Usl Pharma Inc, Alembic Pharmaceuticals Ltd, Specgx Llc, Sandoz Inc, Sun Pharmaceutical Industries Inc, Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc, Watson Laboratories Inc, Actavis Elizabeth Llc, Amneal Pharmaceuticals, Novel Laboratories Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL29463 | |
| PharmGKB | PA451608 | |
| Human Metabolome Database | HMDB0014376 | |
| DrugBank | DB00231 | |
| PubChem: Thomson Pharma | 14873813 | |
| PubChem | 5391 | |
| LINCS | LSM-45470 | |
| Nikkaji | J7.138B | |
| BindingDB | 50408032 | |
| EPA CompTox Dashboard | DTXSID8021309 | |
| DrugCentral | 2585 | |
| Guide to Pharmacology | 7300 | |
| rxnorm | RESTORIL | TEMAZEPAM |
| KEGG Ligand | C07125 | |
| ChEBI | 9435 |
